What is LOPJLB’s current signal on BDTX?

LOPJLB’s latest quantitative signal on Black Diamond Therapeutics, Inc. (BDTX) is SELL in a CRISIS regime. Signals are updated daily.

What market regime is BDTX in?

Black Diamond Therapeutics, Inc. (BDTX) is currently classified in the CRISIS HMM market regime on LOPJLB.

What does Black Diamond Therapeutics, Inc. (BDTX) do?

Black Diamond Therapeutics, Inc. is a biotechnology enterprise dedicated to discovering, advancing, and bringing to market therapeutic agents specifically designed for patients with genetically characterized tumors. A core part of its pipeline is BDTX-189, an irreversible small molecule inhibitor. This compound is engineered to neutralize oncogenic proteins driven by non-canonical epidermal gro…

Where is Black Diamond Therapeutics, Inc. based / listed?

Black Diamond Therapeutics, Inc. is based in US, listed on NASDAQ.

Black Diamond Therapeutics, Inc. (BDTX)

COMPARE

Healthcare · Biotechnology · NASDAQ · US

$1.81-1.09%Close

SELLCRISIS · day 3

[SCORES & PROFILE]

FUND: 13
VALUE: 11
GROWTH: 45
GARP: 6
TYPE: Balanced

Composite of Value · Growth · GARP

ROIC-23.3%

REV YoY-

ROE-38.8%

EPS YoY-

ROA-34.0%

GROSS

NET

[VALUATION]

P/E TTM-2.43

P/E FWD-

SECTOR PE20.12

INDUSTRY PE13.79

P/B1.07

P/FCF-

EV/EBITDA-2.47

EV/EBIT-

PEG-

FCF YIELD-

RISK

INT COV-

D/E17.66

ALTMAN Z-

CURR RATIO7.28

ND/EBITDA-

BETA3.33

Black Diamond Therapeutics, Inc. (BDTX)

Key stats

Industry peers

Prediction markets

FUNDAMENTALS

Company news